Adempas Enrollment Form – Download Fillable PDF for Patients

Adempas Enrollment Form

Patient Support Program

01 Pages

PDF, Fillable PDF

The Adempas enrollment form is an important document required for patients who need to access Adempas through the REMS program. This form verifies patient eligibility, confirms that all safety steps are understood, and ensures that both the prescriber and patient follow the REMS requirements. It also documents consent for counseling, pregnancy testing, and safe-use guidelines. If you need this form, you can download it or fill it out online on StartForms.health.

Adempas Enrollment Form

Safety Rules Assurance

Adempas has specific safety measures due to pregnancy-related risks. The form verifies that the prescriber has provided the required counseling and that the patient understands the testing schedule, safe-use instructions, and ongoing monitoring expectations.

Accurate Reproductive Status Documentation

For female patients, the Adempas enrollment form includes a dedicated section to identify reproductive status. It helps determine whether pregnancy prevention measures, monthly pregnancy testing, or additional counseling are needed before, during, or after treatment.

Simplified Enrollment in REMS Program

Once the form is completed and submitted accurately, the patient is officially enrolled in the Adempas REMS program. It reduces delays and avoids the need for repeated requesting or missing information.

Patient Details

This section includes the patient’s name, mailing address, phone number, and communication preferences.

Diagnosis & Medical Necessity

The prescriber documents the patient’s condition and confirms that Adempas is medically necessary.

Therapy Status

It indicates whether the patient is new to Adempas, continuing treatment, or restarting treatment.

Prescriber Details

Includes the prescriber’s name, NPI, practice details, contact numbers, and identifiers.

Prescriber Certification

The prescriber confirms that counseling, monitoring, and REMS requirements will be followed.

Patient Consent

The patient signs the form to confirm understanding of the risks, requirements, and commitment to follow REMS safety steps.

1

Patient Information: Enter the patient’s full name, date of birth, gender, complete address, preferred phone number, preferred time to contact, and alternative contact details.

2

Statement of Medical Necessity: Indicate the appropriate medical diagnosis and medical necessity.

3

Female Patient Agreement: The patient or their guardian must sign and date the form to confirm understanding of risks, counseling, and REMS requirements.

4

Prescriber Information: Fill in the prescriber’s name, facility name, NPI number, state license number, and complete address.

5

Reproductive Status Details: Female patients must have their reproductive status documented. If of reproductive potential, they require pregnancy counseling and a routine pregnancy test.

6

Prescriber Authorization: The prescriber signs to confirm they will follow all REMS responsibilities.

What is the Adempas enrollment form used for?

It is mandatory because Adempas is available only through a REMS program. The form verifies that the prescriber has completed all required counseling and that the patient understands the risks, monitoring steps, and safety requirements.

Who completes the form?

Both the prescriber and the patient complete their respective sections. Female patients may need additional reproductive information.

Can a patient start Adempas treatment before the submission?

No. The REMS program requires that the Adempas form be fully completed, signed, and accepted before Adempas can be dispensed.

Can I submit this form online?

Of course, you can either submit it through fax or online through the official Adempas REMS website.

Can the information be updated later?

Yes, you can make changes later, such as contact information, treatment status, or reproductive details.

Apply for patient support and access to Xolair treatment for asthma and chronic hives.

Used to enroll patients prescribed Litfulo (ritlecitinib) for access to treatment, insurance coverage assistance, and participation in the Pfizer patient support program.